[Effect of postoperative thoracic radiotherapy on the survival of patients with stage IIIA (N2 disease) non-small-cell lung cancer].
There is still controversy regarding the effective treatment of the patients with non-small cell lung cancer (NSCLC) in stage IIIA (pN2). The radical surgical resection with subsequent adjuvant radiotherapy remains a routine procedure. This research concentrates on the evaluation of the role of adjuvant radiotherapy. The retrospective analysis comprises 162 patients with NSCLC in stage IIIA (pN2) treated in the Department of Surgery, the Institute of Tuberculosis and Lung Diseases, Warsaw, Poland, in years 1988-1993. We conclude that adjuvant radiotherapy in patients with NSCLC stage IIIA (pN2) seems to improve the 5-year survival rate.
Chabowski
Mariusz
M
Klinika Chirurgii Instytutu Gruźlicy i Chorób Płuc w Warszawie.
Orłowski
Tadeusz M
TM
D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011044:Poland; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D016896:Treatment Outcome